Investing.com - Repligen (NASDAQ: RGEN) reported third quarter EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $155M versus the consensus estimate of $153.22M.
Guidance
Repligen sees FY 2024 EPS of $1.50-$1.58 versus the analyst consensus of $1.49.
Repligen sees FY 2024 revenue of $630.00M-$639.00M versus the analyst consensus of $629.70M.
Repligen's stock price closed at $139.51. It is down -5.45% in the last 3 months and down -4.25% in the last 12 months.
Repligen saw 0 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Repligen's stock price’s past reactions to earnings here.
According to InvestingPro, Repligen's Financial Health score is "good performance".
Check out Repligen's recent earnings performance, and Repligen's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar